netbiz

About netbiz

This author has not yet filled in any details.
So far netbiz has created 34 blog entries.

HomeSkinovations Ltd.

Silk’n Partners with Bed Bath & Beyond Silk’n Flash&Go Now Available at All Bed Bath & Beyond Locations in North America
NEW YORK, Jan. 7, 2013 /PRNewswire via COMTEX/ — Bed Bath & Beyond–the go-to resource for home and beauty–recently added the Silk’n Flash&Go all-over permanent hair removal device to all retail doors in the U.S.

NanoPass Technologies Ltd.

NanoPass Technologies Grants a Commercial License to Janssen Pharmaceuticals, Inc., for use of its MicronJet Device
NanoPass Technologies Ltd. (“NanoPass”), a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for MicronJet®, its microneedle delivery device, with Janssen Pharmaceuticals, Inc. (JPI) for multiple vaccine fields.The license agreement will

Gamida Cell Ltd.

First Pediatric Sickle Cell Disease Patient Receives NiCord® Stem Cell Transplantation in Gamida Cell Pilot Study at Duke University
erusalem, Israel, November 12, 2012 — Gamida Cell Ltd., a world leader in stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine, announced today that the first patient, enrolled in its

Argo Medical Technologies Ltd.

ARGO Medical Technologies Announces European Commercial Launch of the ReWalk Exoskeleton for Personal Use ARGO executives and several current users showcase the availability of the ReWalk personal system during REHACARE in Dusseldorf, Germany
DUSSELDORF, Germany, Oct 11, 2012 (BUSINESS WIRE) — Exoskeleton technology leader, ARGO Medical Technologies, today announced that its ReWalk is now commercially available

Argo Medical Technologies Ltd.

Governor Patrick Joins Israeli-Founded ARGO Medical Technologies to Announce Selection of Massachusetts as U.S. Headquarters
BOSTON–(BUSINESS WIRE)–Governor Deval Patrick joined the Massachusetts Life Sciences Center and ARGO Medical Technologies at the AdvaMed 2012 conference in Boston today to announce that Israeli-founded exoskeleton technology leader, ARGO, has selected Massachusetts as its U.S. headquarters.
 “Massachusetts is a global leader

D-Pharm Ltd.

D Pharm expands Chinese cooperation agreement. The agreement with Wanbang Biopharmaceuticals was extended to a new formulation of D Pharm’s treatment for ischemic stroke
D-Pharm Ltd. (TASE: DPRM) has expanded its commercialization agreement with China’s Wanbang Biopharmaceuticals Ltd. for D Pharm’s leading product, DP-b99 for the treatment of ischemic stroke. D Pharm will receive $7.65 million

Gamida Cell Ltd.

Gamida Cell Completes Enrollment for Phase I/II Study of Second Pipeline Product NiCord® for Hematological Malignancies
 
Gamida Cell , a leader in adult stem cell expansion technologies and products, announced today that it has completed enrollment for a Phase I/II clinical trial of NiCord, the company’s second pipeline product.
NiCord is in development as an experimental treatment

Argo Medical Technologies Ltd.

New Era Starts as ReWalk Exoskeleton Technology is Available to Take Home
LONDON–Exoskeleton technology leader, ARGO Medical Technologies, along with mobility solutions provider, Cyclone Technologies, announced today that Claire Lomas has become the first person to take home an exoskeleton system for personal use. Claire demonstrated her personal ReWalk™ at the annual International Spinal Cord Society

NanoPass Technologies Ltd.

NanoPass Secures Series B Investment to Accelerate Commercialization of its Intradermal Delivery Products
NanoPass Technologies Ltd., a pioneer in the development and commercialization of painless intradermal (skin) delivery solutions for vaccines and large molecules, announced today it has recently closed a new round of financing, led by Israel HealthCare Ventures (IHCV), a leading healthcare-dedicated venture capital

Orsense Ltd.

OrSense Introduces Glasswing, its Next-Generation, Wireless, Non-Invasive Hemoglobin Monitoring System for Anemia Screening
Cancun, Mexico, July 9, 2012 – OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, introduced today at the 32nd International Congress of the International Society of Blood Transfusion (ISBT), in Cancun, Mexico, GlasswingTM, its next-generation, wireless, non-invasive hemoglobin (Hb)